Global Precision Medicine Market, By Technology (Bioinformatics, Drug Discovery, Gene Sequencing, Precision Molecular Diagnostics, and Big Data Analytics), By Application (Oncology, CNS, Respiratory, Immunology, Hematology, and Others),
and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) – Trends, Analysis and Forecast till 2030.” Key Highlights: In January 2018, Syapse collaborated with Roche in order to advance precision medicine in oncology. Also, this partnership focuses on clinical delivery and product development for introducing precision medicine to more patients. In March 2018, DSM partnered with Mixfit to provide personalized nutrition solutions by combining Artificial Intelligence (AI) technology. Analyst View: Growing demand and advancements in cancer biology will drive personalized medicine market during the forecast period. Accessibility to large-scale human genome database including next-generation sequencing (NGS) and computational tools foster industry growth. Development of innovative genetic technologies examines the functional effect of genetic makeup that leads to developing cancer, thus, should propel huge demand for cancer biology. Several such tools are widely used to study the mechanism of DNA repair, epigenetic changes related to cancer and gene regulation in cancerous cells that offer opportunities for cancer biology in personalized medicine. Moreover, improving efficiencies within the health care system will serve to be a positive impact rendering factor personalized treatment business growth. Benefits offered by personalized medicines and treatment includes target treatment for the patient, optimal dosing, focus on prevention and earlier intervention as well as preventing adverse events. Thus, the above mentioned features will foster the demand for personalized medication market growth.